Glibenclamide treatment in a Cantú syndrome patient with a

glibenclamide In summary, oral glibenclamide did not increase the absolute rate of a favorable outcome at 90 days in patients with acute ischemic stroke and

Glibenclamide is a long-acting sulfonylurea that has been used safely for decades to treat type 2 diabetes Over the past 20 years, the glibenclamide Exposure to glibenclamide at any stage of pregnancy would not usually be regarded as medical grounds for termination of pregnancy or any additional fetal